1-13 of 13
Jingyu Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating tumor plasma cells as an independent prognostic marker in newly diagnosed multiple myeloma: Clinical correlation and immunophenotypic insights

Free
Yating Li, Yuntong Liu, Jieqiong Zhou, Wenqiang Yan, Jian Cui, Jingyu Xu, Chenxing Du, Shuhui Deng, Yan Xu, Lugui Qiu, Gang An
Journal: Blood
Blood (2025) 146 (Supplement 1): 5761.
https://doi.org/10.1182/blood-2025-5761
Published: 2025
Journal Articles

CART–ASCT–CART2 sandwich regimen as frontline therapy: A phase II trial in patients with primary plasma cell leukemia

Free
Jingyu Xu, Qirui Bai, Yuntong Liu, Wenqiang Yan, Shuaishuai Zhang, Wenyang Huang, Chenxing Du, Lugui Qiu, Gang An
Journal: Blood
Blood (2025) 146 (Supplement 1): 4067.
https://doi.org/10.1182/blood-2025-4067
Published: 2025
Journal Articles

Immunomodulatory drugs rewire mTORC1-dependent pathways in multiple myeloma to trigger cytotoxicity and immunogenic cell death

Free
Jiye Liu, Jingyu Xu, Teru Hideshima, Kenneth Wen, Yuntong Liu, Nikhil Munshi, Lijie Xing, Gang An, Kenneth Anderson
Journal: Blood
Blood (2025) 146 (Supplement 1): 2153.
https://doi.org/10.1182/blood-2025-2153
Published: 2025
Journal Articles

The unique role of PSMD2/Rpn1 among ubiquitin receptors in multiple myeloma highlights its potential as a therapeutic target to overcome proteasome inhibitor resistance

Free
Ting Du, Yuntong Liu, Minxing Wang, Teng Fang, Jingyu Xu, Kenneth Wen, Xueping Wan, Arghya Ray, Sindhu Pillai, Md Abu Musa, Mariateresa Fulciniti, Nikhil Munshi, Yan Song, Kenneth Anderson
Journal: Blood
Blood (2025) 146 (Supplement 1): 2148.
https://doi.org/10.1182/blood-2025-2148
Published: 2025
Journal Articles

CAC-MM-001: A B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Followed By Autologous Stem Cell Transplantation and Second CAR-T (CART-ASCT-CART2) in Newly Diagnosed Multiple Myeloma Patients with P53 Gene Abnormalities

Free
Yuntong Liu, Weiwei Sui, Rui Lyu, Chenxing DU, Shuaishuai Zhang, Tengteng Yu, Jingyu Xu, Wenqiang Yan, Yuting Yan, Wei Liu, Yi Wang, Qi Wang, Yan Xu, Shuhua Yi, Dehui Zou, Lu-Gui Qiu, Gang An
Journal: Blood
Blood (2024) 144 (Supplement 1): 3386.
https://doi.org/10.1182/blood-2024-200117
Published: 2024
Journal Articles

Analysis of Diagnosis and Treatment Pattern for Newly Diagnosed Multiple Myeloma in China over 20 Years

Free
Jingyu Xu, Yuntong Liu, Wenqiang Yan, Lingna Li, Rui Lyu, Chenxing DU, Weiwei Sui, Lugui Qiu, Gang An
Journal: Blood
Blood (2024) 144 (Supplement 1): 6917.
https://doi.org/10.1182/blood-2024-201167
Published: 2024
Journal Articles

Clinical Implications of Residual Immunophenotypically Normal Plasma Cells within Bone Marrow at Various Disease Stages in Multiple Myeloma

Free
Wenqiang Yan, Lihui Shi, Jingyu Xu, Lingna Li, Jian Cui, Chenxing DU, Tengteng Yu, Shuaishuai Zhang, Rui Lv, Weiwei Sui, Shuhui Deng, Yan Xu, Dehui Zou, Lu-Gui Qiu, Mu Hao, Gang An
Journal: Blood
Blood (2024) 144 (Supplement 1): 1932.
https://doi.org/10.1182/blood-2024-199452
Published: 2024
Journal Articles

A Phase 2 Study of CART-ASCT-CART2 Sandwich Regimen Treatment in Patients with Primary Plasma Cell Leukemia

Free
Jingyu Xu, Shuaishuai Zhang, Wenqiang Yan, Yuntong Liu, Rui Lyu, Chenxing DU, Weiwei Sui, Lu-Gui Qiu, Gang An
Journal: Blood
Blood (2024) 144 (Supplement 1): 3389.
https://doi.org/10.1182/blood-2024-200847
Published: 2024
Journal Articles

Hyposecretory Progression Pattern Indicates Inferior Survival of Multiple Myeloma

Free
Jingyu Xu, Wenqiang Yan, Lingna Li, Chenxing Du, Lugui Qiu, Gang An
Journal: Blood
Blood (2023) 142 (Supplement 1): 1955.
https://doi.org/10.1182/blood-2023-178217
Published: 2023
Journal Articles

The Impact of Dynamic Assessment of Risk Stratification at the Time of Disease Progression in Patients with Multiple Myeloma

Free
Huishou Fan, Wenqiang Yan, Jingyu Xu, Chenxing Du, Weiwei Sui, Shuhui Deng, Dehui Zou, Lugui Qiu, Gang An
Journal: Blood
Blood (2022) 140 (Supplement 1): 4371–4373.
https://doi.org/10.1182/blood-2022-157223
Published: 2022
Journal Articles

Is the Second Revision of the International Staging System (R2-ISS) for Multiple Myeloma Valid in a Real-World Population from China?

Free
Wenqiang Yan, Lingna Li, Huishou Fan, Jingyu Xu, Shuhui Deng, Weiwei Sui, Yan Xu, Dehui Zou, Lugui Qiu, Gang An
Journal: Blood
Blood (2022) 140 (Supplement 1): 7255–7256.
https://doi.org/10.1182/blood-2022-158751
Published: 2022
Journal Articles

Impact of Neoplastic Plasma Cells in the Stem Cell Collection on Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation

Free
Jingyu Xu, Lingna Li, Wenqiang Yan, Huishou Fan, Jiahui Liu, Chenxing Du, Shuhui Deng, Weiwei Sui, Yan Xu, Lugui Qiu, Gang An
Journal: Blood
Blood (2022) 140 (Supplement 1): 10011–10012.
https://doi.org/10.1182/blood-2022-165889
Published: 2022
Journal Articles

Real-World Retrospective Study of 46 Patients with Macrofocal Multiple Myeloma (MFMM)

Free
Wenqiang Yan, Huishou Fan, Jingyu Xu, Jiahui Liu, Chenxing Du, Shuhui Deng, Weiwei Sui, Yan Xu, Lugui Qiu, Gang An
Journal: Blood
Blood (2021) 138 (Supplement 1): 3765.
https://doi.org/10.1182/blood-2021-149464
Published: 2021